Real-world Cardiovascular Outcomes Associated With Degarelix vs Leuprolide for Prostate Cancer Treatment
An interesting study that concludes there is no difference in cardio impact between the two drugs.
Real-world Cardiovascular Outcomes Associated With Degarelix vs Leuprolide for Prostate Cancer Treatment
An interesting study that concludes there is no difference in cardio impact between the two drugs.
There was a video about a study posted here recently that showed a large safety advantage for degarelix. Lessened cardiovascular side-effects should have been a major part of that.